Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohort
Annals of Hematology · 13.05.2026 · 105 (7)
DOI: 10.1007/s00277-026-07066-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 13.05.2026. Verfasst von Huiying Shu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Oncology, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, Cheng…. Hauptthemen laut MEDLINE: Spherocytosis, Hereditary, Mutation. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To characterize the clinical and genetic profiles of patients with hereditary spherocytosis (HS) and report novel mutations. This retrospective study included 55 patients (25 males, 30 females; median age 9 years) with HS admitted between 2016 and 2023. Clinical and laboratory data were analyzed. Targeted next-generation sequencing was performed to detect pathogenic mutations. Comparisons were made using Student’s t -test or Mann-Whitney U test. Anemia was present in 53 patients, including 31 with moderate-to-severe anemia; 40 exhibited splenomegaly or gallstones. A total of 60 variants were identified, of which 46 (76.7%) were novel. The most frequently involved genes were ANK1 (28, 50.9%), SPTB (17, 30.9%), SLC4A1 (10, 18.2%), and SPTA1 (2, 3.6%). Patients aged ≤ 3 years ( n = 23) showed significantly lower red blood cell counts, hemoglobin levels, and absolute reticulocyte counts than those aged > 3 years ( n = 32) (all P < 0.05), whereas no significant phenotypic differences were observed across mutation types. Younger patients with HS exhibited more severe anemia. ANK1 and SPTB were the predominant pathogenic genes, with no notable phenotypic differences between these two genotypes. The identification of 46 novel mutations expands the mutational spectrum of HS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology & Oncology, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, 611731, China.
- Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, 350001, China.
- Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China. pjjwz2025@163.com.
Zitieren
APA
Shu, H., Yang, L., Gao, Y., Yun, X., Zhou, M., & Gong, Y. (2026). Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohort. Annals of Hematology, 105(7). https://doi.org/10.1007/s00277-026-07066-1
Vancouver
Shu H, Yang L, Gao Y, Yun X, Zhou M, Gong Y. Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohort. Annals of Hematology. 2026;105(7). doi:10.1007/s00277-026-07066-1
BibTeX
@article{Shu2026,
author = {Shu, Huiying and Yang, Liqing and Gao, Yu and Yun, Xuexue and Zhou, Min and Gong, Yuping},
title = {Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohort},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {7},
doi = {10.1007/s00277-026-07066-1}
}
EUVIMED